TransMedics Group, Inc. Revenue
TransMedics Group, Inc. (TMDX) reported Revenue of $189.95 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2026-08-04
- TransMedics Group, Inc. revenues for the quarter ending 2026-06-30 was $189.95M, a 20.70% increase year-over-year.
- TransMedics Group, Inc. revenues for the quarter ending 2026-03-31 was $173.93M, a 21.18% increase year-over-year.
- TransMedics Group, Inc. revenues for the quarter ending 2025-12-31 was $160.76M, a 32.18% increase year-over-year.
- TransMedics Group, Inc. revenues for the quarter ending 2025-09-30 was $143.82M, a 32.24% increase year-over-year.
- TransMedics Group, Inc. revenues for fiscal 2025 was $605.49M, a 37.13% increase from fiscal 2024.
- TransMedics Group, Inc. revenues for fiscal 2024 was $441.54M, a 82.74% increase from fiscal 2023.
- TransMedics Group, Inc. revenues for fiscal 2023 was $241.62M, a 158.53% increase from fiscal 2022.
- TransMedics Group, Inc. revenues for fiscal 2022 was $93.46M, a 208.83% increase from fiscal 2021.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2026-06-30 | $189.95M 10-Q · filed 2026-08-04 | $363.88M 10-Q · filed 2026-08-04 | $524.64M derived: sum of 3 quarters · filed 2026-08-04 | $668.47M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $173.93M 10-Q · filed 2026-05-05 | $334.70M derived: sum of 2 quarters · filed 2026-05-05 | $478.52M derived: sum of 3 quarters · filed 2026-05-05 | $635.89M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $160.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $304.59M derived: sum of 2 quarters · filed 2026-02-24 | $461.96M derived: sum of 3 quarters · filed 2026-08-04 | $605.49M 10-K · filed 2026-02-24 |
| 2025-09-30 | $143.82M 10-Q · filed 2025-10-29 | $301.19M derived: sum of 2 quarters · filed 2026-08-04 | $444.73M 10-Q · filed 2025-10-29 | $566.35M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $157.37M 10-Q · filed 2026-08-04 | $300.91M 10-Q · filed 2026-08-04 | $422.53M derived: sum of 3 quarters · filed 2026-08-04 | $531.29M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $143.54M 10-Q · filed 2026-05-05 | $265.16M derived: sum of 2 quarters · filed 2026-05-05 | $373.92M derived: sum of 3 quarters · filed 2026-05-05 | $488.23M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $121.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $230.38M derived: sum of 2 quarters · filed 2026-02-24 | $344.69M derived: sum of 3 quarters · filed 2026-02-24 | $441.54M 10-K · filed 2026-02-24 |
| 2024-09-30 | $108.76M 10-Q · filed 2025-10-29 | $223.07M derived: sum of 2 quarters · filed 2025-10-29 | $319.92M 10-Q · filed 2025-10-29 | $401.09M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $114.31M 10-Q · filed 2025-07-30 | $211.16M 10-Q · filed 2025-07-30 | $292.33M derived: sum of 3 quarters · filed 2026-02-24 | $358.76M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $96.85M 10-Q · filed 2025-05-08 | $178.02M derived: sum of 2 quarters · filed 2026-02-24 | $244.45M derived: sum of 3 quarters · filed 2026-02-24 | $296.92M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $81.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $147.60M derived: sum of 2 quarters · filed 2026-02-24 | $200.07M derived: sum of 3 quarters · filed 2026-02-24 | $241.62M 10-K · filed 2026-02-24 |
| 2023-09-30 | $66.43M 10-Q · filed 2024-10-29 | $118.89M derived: sum of 2 quarters · filed 2024-10-29 | $160.45M 10-Q · filed 2024-10-29 | $191.82M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $52.47M 10-Q · filed 2024-08-01 | $94.02M 10-Q · filed 2024-08-01 | $125.39M derived: sum of 3 quarters · filed 2025-02-27 | $151.08M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $41.55M 10-Q · filed 2024-05-02 | $72.93M derived: sum of 2 quarters · filed 2025-02-27 | $98.61M derived: sum of 3 quarters · filed 2025-02-27 | $119.13M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $31.38M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $57.06M derived: sum of 2 quarters · filed 2025-02-27 | $77.58M derived: sum of 3 quarters · filed 2025-02-27 | $93.46M 10-K · filed 2025-02-27 |
| 2022-09-30 | $25.68M 10-Q · filed 2023-11-08 | $46.20M derived: sum of 2 quarters · filed 2023-11-08 | $62.08M 10-Q · filed 2023-11-08 | $71.75M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $20.52M 10-Q · filed 2023-08-04 | $36.40M 10-Q · filed 2023-08-04 | $46.07M derived: sum of 3 quarters · filed 2024-02-27 | $51.44M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $15.88M 10-Q · filed 2023-05-04 | $25.55M derived: sum of 2 quarters · filed 2024-02-27 | $30.92M derived: sum of 3 quarters · filed 2024-02-27 | $39.09M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $9.67M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $15.04M derived: sum of 2 quarters · filed 2024-02-27 | $23.21M derived: sum of 3 quarters · filed 2024-02-27 | $30.26M 10-K · filed 2024-02-27 |
| 2021-09-30 | $5.37M 10-Q · filed 2022-11-04 | $13.54M derived: sum of 2 quarters · filed 2022-11-04 | $20.59M 10-Q · filed 2022-11-04 | $28.22M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $8.17M 10-Q · filed 2022-08-03 | $15.22M 10-Q · filed 2022-08-03 | $22.85M derived: sum of 3 quarters · filed 2022-08-03 | $29.94M derived: sum of 4 quarters · filed 2022-08-03 |
| 2021-03-31 | $7.05M 10-Q · filed 2022-05-05 | $14.68M derived: sum of 2 quarters · filed 2022-05-05 | $21.77M derived: sum of 3 quarters · filed 2022-05-05 | $25.16M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $7.63M 10-K · filed 2021-03-11 | $14.72M derived: sum of 2 quarters · filed 2021-11-09 | $18.11M derived: sum of 3 quarters · filed 2021-11-09 | $25.64M 10-K · filed 2021-03-11 |
| 2020-09-30 | $7.09M 10-Q · filed 2021-11-09 | $10.48M derived: sum of 2 quarters · filed 2021-11-09 | $18.01M 10-Q · filed 2021-11-09 | $24.07M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $3.39M 10-Q · filed 2021-08-06 | $10.92M 10-Q · filed 2021-08-06 | $16.98M derived: sum of 3 quarters · filed 2021-08-06 | $24.18M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $7.53M 10-K · filed 2021-03-11 | $13.59M derived: sum of 2 quarters · filed 2021-05-07 | $20.79M derived: sum of 3 quarters · filed 2021-05-07 | $26.46M derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-28 | $6.06M 10-K · filed 2021-03-11 | $13.26M derived: sum of 2 quarters · filed 2021-03-11 | $18.93M derived: sum of 3 quarters · filed 2021-03-11 | $23.60M 10-K · filed 2021-03-11 |
| 2019-09-28 | $7.21M 10-K · filed 2021-03-11 | $12.87M derived: sum of 2 quarters · filed 2021-03-11 | $17.55M 10-Q · filed 2019-11-08 | $21.09M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-06-29 | $5.67M 10-K · filed 2021-03-11 | $10.34M 10-Q · filed 2020-08-07 | $13.89M derived: sum of 3 quarters · filed 2021-03-11 | $17.93M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-03-30 | $4.68M 10-K · filed 2021-03-11 | $8.22M derived: sum of 2 quarters · filed 2021-03-11 | $12.26M derived: sum of 3 quarters · filed 2021-03-11 | $15.17M derived: sum of 4 quarters · filed 2021-03-11 |
| 2018-12-29 | $3.54M 10-K · filed 2020-03-17 | $7.58M derived: sum of 2 quarters · filed 2020-03-17 | $10.50M derived: sum of 3 quarters · filed 2020-03-17 | $13.02M 10-K · filed 2020-03-17 |
| 2018-09-29 | $4.04M 10-K · filed 2020-03-17 | $6.95M derived: sum of 2 quarters · filed 2020-03-17 | $9.47M 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $2.92M 10-K · filed 2020-03-17 | $5.43M 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $2.52M 10-K · filed 2020-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |